Drug modifies epigenome in aggressive brain tumors



Drug modifies epigenome in aggressive brain tumors

The researchers showed for the first time that the DNA methylome of these brain tumors can be reprogrammed. The study said that this is the first time DNA methylome reprogramming has occurred with any solid human tumor.

Materials provided by Vanderbilt University Medical Center. Original written by Tom Wilemon. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

9th December 2022

Clues found regarding tumor suppressor gene's breast cancer activity

Read more
9th December 2022

New findings on how to avert excessive weight loss from COVID-19

Read more
9th December 2022

P53 could be key to therapies for salivary gland cancer

Read more